Micar Innovation Business Model an biopharmaceutical company profitable and firmly anchored in its community
Micar Innovation business model and organization are predicated on the co-existence of four business streams /Licensing of our own Pipeline, Parthership, Project: 22 new treatments of rare and ultra rare diseases, Factory for Drug Discovery of novel compounds for the treatment of diversity diseases/ that respectively provide short, medium and long-term revenue streams.
Founded in 2016, Micar Innovation is built on a balanced business model. Micar Innovation capital is in the hands of its top management. Thus, the interests of its management remain perfectly aligned.